《港股》恆指高開77點 騰訊及恆隆地產揚
亞馬遜升逾4%帶動納指及標普500指數升近1%及0.8%,道指亦升0.8%。港股早市高開,恆指高開77點或0.3%,報25,136點;國指高開22點或0.3%,報8,960點;恆生科技指數高開23點或0.4%,報5,602點。
阿里(09988.HK)啟動未到期優先票據交換要約,涉資26.5億美元,股價低開1%報128.5元。其他科技股方面,騰訊(00700.HK)、中芯(00981.HK)及京東(09618.HK)高開1.1%至1.4%,美團(03690.HK)及嗶哩嗶哩(09626.HK)各低開0.1%,快手(01024.HK)及百度(09888.HK)高開0.1%及0.5%,網易(09999.HK)平開報207.8元。
車股方面,小米(01810.HK)計劃2027年實現汽車出海,股價高開1%報54元,比亞迪(01211.HK)平開報104.5元,理想(02015.HK)及小鵬(09868.HK)高開0.9%及0.2%,蔚來(09866.HK)及吉利(00175.HK)低開0.1%及0.4%。
新地(00016.HK)年度基礎溢利218.5億符預期,股價平開報91.4元。恆隆地產(00101.HK)高開1.6%,早段升幅擴大,高盛發表報告指恆隆旗下內地租戶銷售進一步改善。
內房股中海外(00688.HK)8月合約物業銷售按年跌0.7%,股價高開1.2%。復星(00656.HK)附屬3.1億歐元售葡萄牙私人醫療集團40%股權,股價高開1.3%報5.34元。
國務院發布《關於釋放體育消費潛力進一步推進體育產業高質量發展的意見》提出,到2030年,培育一批具有世界影響力的體育企業和體育賽事,體育產業發展水平大幅躍升,總規模超過7萬億元人民幣。體育用品股李寧(02331.HK)及安踏(02020.HK)高開3.5%及1.9%。
藥股石藥(01093.HK)、藥明康德(02359.HK)、中生製藥(01177.HK)及翰森(03692.HK)各高開逾1%。其他股份方面,匯控(00005.HK)高開0.9%報100.5元,港交所(00388.HK)高開0.4%,友邦(01299.HK)低開不足0.1%報71.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.